Position in PROK
as of Mar 31, 2026
· filed Jun 24, 2026
Position Value
$1,048
-$564 QoQ
Shares Held
586
-18.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PROK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Basecamp Wealth Advisors LLC holds $1,365,473 across 110 Biotechnology names. PROK ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
788 | $351,873 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
203 | $156,845 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
265 | $78,697 | |
| 4 | MRNA |
Moderna, Inc.
|
994 | $50,495 | |
| 5 | ZLAB |
Zai Lab Ltd
|
2,683 | $50,467 | |
| 6 | TECH |
BIO-TECHNE Corp
|
960 | $50,169 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
150 | $49,630 | |
| 8 | RPRX |
Royalty Pharma plc
|
972 | $46,626 |
All Filings in PROK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,048 | 586 | Shares | Sole | 2026-06-24 | |
| 2025-12-31 | $1,612 | 720 | Shares | Sole | 2026-06-24 | |
| No filing history on record for this holder in this stock. | ||||||